mTOR as a therapeutic target in patients
β
Salah-Eddin Al-Batran; Michel Ducreux; Atsushi Ohtsu
π
Article
π
2011
π
John Wiley and Sons
π
French
β 235 KB
π 1 views
## Abstract The poor longβterm outcomes associated with current chemotherapy treatment of patients with advanced gastric cancer suggest a need for novel targeted agents that may confer a better survival benefit. Evidence of mammalian target of rapamycin (mTOR) activation has been demonstrated in pa